Introduction of High Throughput Magnetic Resonance T2-Weighted Image Texture Analysis for WHO Grade 2 and 3 Gliomas
暂无分享,去创建一个
Naoki Kagawa | Katsuyuki Nakanishi | Naoya Hashimoto | Toshiki Yoshimine | Yonehiro Kanemura | Mio Sakai | Hideyuki Arita | Manabu Kinoshita | Tomoko Shofuda | T. Yoshimine | Yoshiyuki Watanabe | T. Shofuda | Y. Kanemura | M. Kinoshita | Naoki Kagawa | H. Arita | N. Hashimoto | Y. Fujimoto | Yoshiyuki Watanabe | K. Nakanishi | Yasunori Fujimoto | Yasuyoshi Chiba | M. Sakai | Y. Chiba | Hideyuki Arita
[1] A. Marchetti,et al. IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors , 2009, Human mutation.
[2] B. Rosen,et al. Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate. , 2013, The Journal of clinical investigation.
[3] John F. Canny,et al. A Computational Approach to Edge Detection , 1986, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[4] T. Yoshimine,et al. IDH1/2 mutation detection in gliomas , 2015, Brain Tumor Pathology.
[5] Kuniaki Saito,et al. H3F3A K27M mutations in thalamic gliomas from young adult patients. , 2014, Neuro-oncology.
[6] T. Cloughesy,et al. Probabilistic Radiographic Atlas of Glioblastoma Phenotypes , 2013, American Journal of Neuroradiology.
[7] E. Shaw,et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[9] CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion. , 2012, Neuro-oncology.
[10] Zhaoshi Jiang,et al. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Dinesh Rakheja,et al. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated glioma patients , 2011, Nature Medicine.
[12] Sang Joon Park,et al. Glioma: Application of Whole-Tumor Texture Analysis of Diffusion-Weighted Imaging for the Evaluation of Tumor Heterogeneity , 2014, PloS one.
[13] T. Yoshimine,et al. CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion. , 2012, Neuro-oncology.
[14] Satoru Miyano,et al. Mutational landscape and clonal architecture in grade II and III gliomas , 2015, Nature Genetics.
[15] Alexander R. Pico,et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. , 2015, The New England journal of medicine.
[16] Robert J. Harris,et al. Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: A radiographic study in 358 de novo human glioblastomas , 2012, NeuroImage.
[17] Ovidiu C. Andronesi,et al. Detection of 2-Hydroxyglutarate in IDH-Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance Spectroscopy , 2012, Science Translational Medicine.
[18] K. Chang,et al. Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[19] Ryuta Saito,et al. Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas , 2015, Brain Tumor Pathology.
[20] Y. Iwadate,et al. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography. , 2011, Journal of neurosurgery.